S&P Futures
3,796.50 -24.75 (-0.65%) Dow Futures
30,834.00 -165.00 (-0.53%) Nasdaq Futures
11,603.75 -87.25 (-0.75%) Russell 2000 Futures
1,710.30 -11.10 (-0.64%) Crude Oil
110.04 +0.26 (+0.24%) Gold
1,817.40 -0.10 (-0.01%)
Kinder Morgan, Inc. (KMI)
After hours:
Chart Events
Performance Outlook
| Previous Close | 17.20 |
| Open | 17.42 |
| Bid | 0.00 x 1800 |
| Ask | 0.00 x 3000 |
| Day's Range | 16.85 - 17.49 |
| 52 Week Range | 15.01 - 20.20 |
| Volume | |
| Avg. Volume | 17,121,064 |
| Market Cap | 38.365B |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | 22.03 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.11 (5.92%) |
| Ex-Dividend Date | Apr 29, 2022 |
| 1y Target Est | N/A |
- Business Wire
Permian Highway Pipeline Announces Final Investment Decision for Expansion Project
HOUSTON, June 29, 2022--Permian Highway Pipeline, LLC announced a final investment decision (FID) to proceed with its expansion project.
- Business Wire
Gulf Coast Express Pipeline Announces Open Season for Expansion Project
HOUSTON, May 16, 2022--Gulf Coast Express Pipeline LLC (GCX) today announced an open season to solicit commitments for an expansion project on its system.
- Business Wire
Gamida Cell Presents Updated Omidubicel Data During Best Abstract Award Session at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
BOSTON, April 26, 2022--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with solid and hematological cancers and other serious diseases, today announced that updated infection data on omidubicel in comparison to umbilical cord blood transplantation (UCB), was shared in an oral presentation at the 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (TCT), being held in Salt Lake City, UT, April 23-26, 2022.
